Aiforia signs new clinical account in France
Translation: Original published in Finnish on 5/19/2025 at 2:14 pm EEST.
Nantes University Hospital will deploy Aiforia's software in clinical diagnostics. The value of the two-year agreement was not communicated in the release. Nantes is the sixth largest university hospital in France, and its catchment area has a population of 800,000. Based on this and the value of Aiforia's previous customer relationships, we estimate that the customer relationship corresponds to less than EUR 100,000 in annual revenue in the initial phase. According to the release, the agreement only includes a part of the company's image recognition models, so the customer relationship has potential for expansion already with the company's current product portfolio.
This is Aiforia's second clinical segment agreement in France, where the Assistance Publique - Hôpitaux de Paris (AP-HP hospital group) adopted Aiforia in 2024. Although the now-announced agreement is relatively small in size, it still sends a good message about the company's market position and the pace at which the market is forming. The release supports our forecasts of strong revenue growth but does not create pressure for forecast changes.
Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of areas from oncology to neuroscience. Aiforia Technologies is headquartered in Finland.
Read more on company pageKey Estimate Figures23.04
| 2024 | 25e | 26e | |
|---|---|---|---|
| Revenue | 2.9 | 4.7 | 7.6 |
| growth-% | 18.9 % | 65.7 % | 60.0 % |
| EBIT (adj.) | -12.2 | -11.9 | -12.0 |
| EBIT-% (adj.) | -427.8 % | -252.9 % | -158.1 % |
| EPS (adj.) | -0.41 | -0.37 | -0.38 |
| Dividend | 0.00 | 0.00 | 0.00 |
| Dividend % | |||
| P/E (adj.) | neg. | neg. | neg. |
| EV/EBITDA | neg. | neg. | neg. |